scispace - formally typeset
A

Annunziata Mauro

Researcher at University of Teramo

Publications -  63
Citations -  1367

Annunziata Mauro is an academic researcher from University of Teramo. The author has contributed to research in topics: Stem cell & Amniotic epithelial cells. The author has an hindex of 22, co-authored 51 publications receiving 1074 citations. Previous affiliations of Annunziata Mauro include University of L'Aquila.

Papers
More filters
Journal ArticleDOI

PKCα-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells

TL;DR: Notably, sarcomeric myosin expression is induced by both TPA and UO126 but is abrogated by the p38 inhibitor, which indicates a pivotal role for p38 in controlling the myogenic program.
Journal ArticleDOI

The role of Akt signalling in the mammalian ovary.

TL;DR: The serine/threonine protein kinase Akt is involved in many cellular processes including cell growth, survival, proliferation and metabolism, and is associated with several human diseases including infertility and ovarian cancer.
Journal ArticleDOI

p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells

TL;DR: The results of this study suggest that the targeting of MEK/ERKs to rescue p21WAF1 expression and myogenic transcription factor functions leads to the reversal of the Rhabdomyosarcoma phenotype.
Journal ArticleDOI

Isolation, characterization, and in vitro differentiation of ovine amniotic stem cells

TL;DR: Ovine amniotic fluid-derived SCs collected from the membranes or fluid were found to proliferate, express the pluripotent SC markers OCT-4 and TERT, and differentiate in both osteogenic and smooth muscle lineages in vitro.
Journal ArticleDOI

Achilles tendon regeneration can be improved by amniotic epithelial cell allotransplantation.

TL;DR: It is demonstrated that AECs can support tendon regeneration, and their effects may be used to develop future strategies to treat tendon disease characterized by a poor clinical outcome in veterinary medicine.